169 related articles for article (PubMed ID: 35018826)
1. Distinctive Clinical and Pathologic Features of Immature Teratomas Arising from Induced Pluripotent Stem Cell-Derived Beta Cell Injection in a Diabetes Patient.
Han L; He H; Yang Y; Meng Q; Ye F; Chen G; Zhang J
Stem Cells Dev; 2022 Mar; 31(5-6):97-101. PubMed ID: 35018826
[TBL] [Abstract][Full Text] [Related]
2. Cisplatin induces differentiation in teratomas derived from pluripotent stem cells.
Kurata A; Takanashi M; Ohno SI; Fujita K; Kuroda M
Regen Ther; 2021 Dec; 18():117-126. PubMed ID: 34141836
[TBL] [Abstract][Full Text] [Related]
3. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model.
Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG
Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788
[TBL] [Abstract][Full Text] [Related]
4. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
5. Jazf1 acts as a regulator of insulin-producing β-cell differentiation in induced pluripotent stem cells and glucose homeostasis in mice.
Park SJ; Kwon W; Park S; Jeong J; Kim D; Jang S; Kim SY; Sung Y; Kim MO; Choi SK; Ryoo ZY
FEBS J; 2021 Jul; 288(14):4412-4427. PubMed ID: 33555104
[TBL] [Abstract][Full Text] [Related]
6. Treating iPSC-Derived β Cells with an Anti-CD30 Antibody-Drug Conjugate Eliminates the Risk of Teratoma Development upon Transplantation.
Pellegrini S; Zamarian V; Landi E; Cospito A; Lombardo MT; Manenti F; Citro A; Schiavo Lena M; Piemonti L; Sordi V
Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077097
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic Endoderm-Derived From Diabetic Patient-Specific Induced Pluripotent Stem Cell Generates Glucose-Responsive Insulin-Secreting Cells.
Rajaei B; Shamsara M; Amirabad LM; Massumi M; Sanati MH
J Cell Physiol; 2017 Oct; 232(10):2616-2625. PubMed ID: 27306424
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus.
Agrawal A; Narayan G; Gogoi R; Thummer RP
Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962
[TBL] [Abstract][Full Text] [Related]
9. Direct
Xiang M; Lu M; Quan J; Xu M; Meng D; Cui A; Li N; Liu Y; Lu P; Kang X; Wang X; Sun N; Zhao M; Liang Q; Le L; Wang X; Zhang J; Chen S
Theranostics; 2019; 9(1):290-310. PubMed ID: 30662568
[TBL] [Abstract][Full Text] [Related]
10. Strategies to Improve the Safety of iPSC-Derived β Cells for β Cell Replacement in Diabetes.
Pellegrini S; Zamarian V; Sordi V
Transpl Int; 2022; 35():10575. PubMed ID: 36090777
[TBL] [Abstract][Full Text] [Related]
11. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus.
Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA
Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998
[TBL] [Abstract][Full Text] [Related]
12. An Ethanol Extract of
Kim A; Baek SJ; Shin S; Lee SY; Chung SK
Nutrients; 2023 May; 15(10):. PubMed ID: 37242247
[TBL] [Abstract][Full Text] [Related]
13. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells.
Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG
Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255
[TBL] [Abstract][Full Text] [Related]
14. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells.
Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H
Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313
[TBL] [Abstract][Full Text] [Related]
15. Noninvasive detection of human-induced pluripotent stem cell (hiPSC)-derived teratoma with an integrin-targeting agent (99m)Tc-3PRGD2.
Li Y; Liu Z; Dong C; He P; Liu X; Zhu Z; Jia B; Li F; Wang F
Mol Imaging Biol; 2013 Feb; 15(1):58-67. PubMed ID: 22707047
[TBL] [Abstract][Full Text] [Related]
16. Applications of iPSC-derived beta cells from patients with diabetes.
Maxwell KG; Millman JR
Cell Rep Med; 2021 Apr; 2(4):100238. PubMed ID: 33948571
[TBL] [Abstract][Full Text] [Related]
17. Teratoma formation by human embryonic stem cells: evaluation of essential parameters for future safety studies.
Hentze H; Soong PL; Wang ST; Phillips BW; Putti TC; Dunn NR
Stem Cell Res; 2009 May; 2(3):198-210. PubMed ID: 19393593
[TBL] [Abstract][Full Text] [Related]
18. Suspension culture improves iPSC expansion and pluripotency phenotype.
Cuesta-Gomez N; Verhoeff K; Dadheech N; Dang T; Jasra IT; de Leon MB; Pawlick R; Marfil-Garza B; Anwar P; Razavy H; Zapata-Morin PA; Jickling G; Thiesen A; O'Gorman D; Kallos MS; Shapiro AMJ
Stem Cell Res Ther; 2023 Jun; 14(1):154. PubMed ID: 37280707
[TBL] [Abstract][Full Text] [Related]
19. Generation of disease-specific induced pluripotent stem cells from patients with rheumatoid arthritis and osteoarthritis.
Lee J; Kim Y; Yi H; Diecke S; Kim J; Jung H; Rim YA; Jung SM; Kim M; Kim YG; Park SH; Kim HY; Ju JH
Arthritis Res Ther; 2014 Feb; 16(1):R41. PubMed ID: 24490617
[TBL] [Abstract][Full Text] [Related]
20. Reversible transformation and de-differentiation of human cells derived from induced pluripotent stem cell teratomas.
Kamada M; Mitsui Y; Matsuo T; Takahashi T
Hum Cell; 2016 Jan; 29(1):1-9. PubMed ID: 26069211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
